How to use Technology Offers

Product name

Identifying and purifying cancer stem cell from cell sample

Summary

rapid, efficient and reproducible method for identifying and purifying stem cancer-initiating cells, notably from cancers of the central and peripheral system

Organization name

Université Genève

Profile

Invention

Cancer stem-like cells represent a potential source of tumor cell expansions. Understanding how these cancer-initiating stem cells emerge and progress are thus crucial in determining the biological behavior of tumors and in developing possible drug target therapies.

Scientists at the University of Genf have established a rapid, efficient and reproducible method for identifying and purifying stem cancer-initiating cells, notably from cancers of the central and peripheral system. Those cells show self renewal, differentiation and tumorigenic properties in vitro and in vivo.

Applications

A rapid and liable method of detecting the presence of cancer stem cells in a tumor cell sample.
Identify specific biomarkers to develop a diagnostic test and potential target therapies.
Use of a homogeneous population of cancer stem cells for screening for antitumor agents.

Stage of developement

Methodology for identifying and purifying cancer stem cells
in vitro and in vivo characterization of purified cancer stem cells.

Collaboration and licensing opportunity

The University of Geneva is seeking a commercial partner:

to sponsor further research on the intrinsic properties of purified cancer stem cells.
to license the US provisional pending patent describing the methodology

Contact

Dr. Deloche

olivier.deloche(at)unige.ch